1-3 of 3
Wen-Jing Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Safety and Efficacy between Venetoclax Combined with CAG (cytarabine, aclarubicin, G-CSF) Regimen and CAG Regimen Alone in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Wen-Jing Yu, Ying Wu, Qi Chen, Xiaolu Zhu, Xu-Ying Pei, Jin-Song Jia, Jing Wang, Xiao-Su Zhao, Ying-Jun Chang, Yue-Yun Lai, Hong-Xia Shi, Guo-Rui Ruan, Ya-Zhen Qin, Xiao-Hong Liu, Xiao Jun Huang, Hao Jiang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1525.
https://doi.org/10.1182/blood-2023-184665
Published: 2023
Journal Articles

Anti-PD-1 Antibody (Sintilimab) Plus Decitabine As First Line Treatment for Patients with Higher-Risk Myelodysplastic Syndrome (MDS): Primary Results from a Single-Arm,Open-Label,Phase II Study

Jing Wang, Siqi Li, Hao Jiang, Ying-Jun Chang, Xiao-su Zhao, Jinsong JIA, Xiaolu Zhu, Lizhong Gong, Xiaohong Liu, Wen-Jing Yu, Xiaojun Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4600.
https://doi.org/10.1182/blood-2023-174600
Published: 2023
Journal Articles

Safety and Short-Term Efficacy of Venetoclax Combined with Azacitidine in Acute Myeloid Leukemia: A Single Institution Experience

Wen-Jing Yu, Jinsong JIA, Jing Wang, Fei-Fei Tang, Lizhong Gong, Xiaohong Liu, Xiaolu Zhu, Xiaosu Zhao, Xiao Jun Huang, Hao Jiang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4413.
https://doi.org/10.1182/blood-2021-148259
Published: 2021